Overview

Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look at the efficacy and safety of leuprolide acetate in patients with prostate cancer.
Phase:
Phase 3
Details
Lead Sponsor:
GP-Pharm
Treatments:
Leuprolide